Test can detect HIV resistance before viral load increase
This article was originally published in Clinica
Executive Summary
ViroLogic has released data that show that its PhenoSense HIV phenotypic resistance assay can detect the emergence of viral drug resistance in HIV patients before a significant increase in the viral load is apparent. This is the first time that this has been demonstrated, ViroLogic says, and may have important implications for the management of patients receiving antiretroviral therapy.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.